Scientist/Senior Scientist, Vascular jobs in United States
cer-icon
Apply on Employer Site
company-logo

NewLimit · 3 months ago

Scientist/Senior Scientist, Vascular

positionSouth San Francisco, CA
timeFull-time
remoteOnsite
senioritySenior Level
date5+ years exp

NewLimit is a biotechnology company focused on extending human healthspan through innovative medicines. They are seeking a Scientist/Senior Scientist with expertise in endothelial biology to develop assays and collaborate on reprogramming medicines aimed at treating age-related diseases.

BiotechnologyClinical TrialsHealth Care
check
H1B Sponsor Likelynote

Responsibilities

Develop functional assays and pre-clinical models to measure endothelial cell function
Collaborate with our Functional Genomics and Predictive Modeling teams to test reprogramming hypotheses at scale
Measure the impact of mRNA reprogramming medicines on endothelial cell function
Engineer in vivo nucleic acid delivery methods for endothelial cells
Analyze and interpret experimental data to drive pre-clinical decision making

Qualification

Endothelial biologyFunctional assays developmentMouse models experienceTransgenic manipulationSingle cell genomicsData analysisCollaboration skills

Required

Ph.D. in cell biology, molecular biology, biochemistry or a related field or equivalent industry experience (5+ years)
Experience with primary endothelial cell isolation and functional characterization
Experience working with mouse models of endothelial cell function (e.g. kidney, cardiovascular, or cognitive disease models)
Experience with transgenic manipulation of endothelial cells either ex vivo or in vivo (e.g. using viral vectors, nucleic acid delivery)

Preferred

History of contributing to a drug development program at the pre-clinical or clinical development stage
Experience leading the design and execution of pre-clinical studies in mouse models
Experience with single cell genomics methods
Experience with pooled screening approaches using bulk or single cell read-outs (e.g. CRISPR fitness screens, Perturb/CROP-seq)

Company

NewLimit

twittertwittertwitter
company-logo
NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.
dateFounded in 2022
location
South San Francisco, California, USA
people-size11-50 employees
web-link
https://www.newlimit.com

H1B Sponsorship

NewLimit has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (2)

Funding

Current Stage
Growth Stage
Total Funding
$247.25M
Key Investors
Kleiner Perkins
2025-10-20Convertible Note· $45M
2025-05-06Series B· $130M
2023-05-16Series A· $72.25M

Leadership Team

leader-logo
Blake Byers
Co-Founder
linkedin

Recent News

Benzinga.com
Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It
2026-01-06
Longevity.Technology - Latest News, Opinions, Analysis and Research
NewLimit ‘close’ to clinic-ready epigenetic reprogramming therapy
2025-11-28
Crunchbase News
Longevity Startup Funding Sees Fewer Moonshots, But Plenty Of Buzzy Investments
2025-11-17
Company data provided by crunchbase